Summary

Eligibility
for people ages 3-18 (full criteria)
Location
at UCSD
Dates
study started
completion around
Principal Investigator
by Kathryn Akong, MD (ucsd)

Description

Summary

The STOP PEDS RCT is a multicenter, parallel, open label randomized controlled trial evaluating the long-term (one year) and short-term safety and efficacy of two antibiotic treatment strategies for the management of outpatient pulmonary exacerbations (PEx) in the pediatric CF population.

Official Title

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics Randomized Controlled Trial (STOP PEDS RCT)

Details

Keywords

Cystic Fibrosis, oral antibiotics, pulmonary exacerbation, pediatric, Fibrosis, Anti-Bacterial Agents, Antitubercular Antibiotics, Immediate Oral Antibiotics, Tailored Treatment: Oral Antibiotics only if Additional Treatment needed, Immediate Antibiotics, Tailored Therapy

Eligibility

Locations

Lead Scientist at University of California Health

  • Kathryn Akong, MD (ucsd)
    Clinical Professor, Pediatrics, Vc-health Sciences-schools. Authored (or co-authored) 14 research publications

Details

Status
accepting new patients at some sites,
but this study is not currently recruiting here
Start Date
Completion Date
(estimated)
Sponsor
University of Washington, the Collaborative Health Studies Coordinating Center
Links
STOP PEDS Pilot Study manuscript
ID
NCT06654752
Study Type
Interventional
Participants
Expecting 430 study participants
Last Updated